cilostazol

Generic: cilostazol

Labeler: aphena pharma solutions - tennessee, llc
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name cilostazol
Generic Name cilostazol
Labeler aphena pharma solutions - tennessee, llc
Dosage Form TABLET
Routes
ORAL
Active Ingredients

cilostazol 100 mg/1

Manufacturer
Aphena Pharma Solutions - Tennessee, LLC

Identifiers & Regulatory

Product NDC 71610-822
Product ID 71610-822_15ead24d-7d6b-b7ad-e063-6294a90ab1bb
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA077030
Listing Expiration 2026-12-31
Marketing Start 2011-10-18

Pharmacologic Class

Established (EPC)
phosphodiesterase 3 inhibitor [epc]
Mechanism of Action
phosphodiesterase 3 inhibitors [moa]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 71610822
Hyphenated Format 71610-822

Supplemental Identifiers

RxCUI
242461
UNII
N7Z035406B
NUI
N0000175598 N0000175086

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name cilostazol (source: ndc)
Generic Name cilostazol (source: ndc)
Application Number ANDA077030 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 100 mg/1
source: ndc
Packaging
  • 1200 TABLET in 1 BOTTLE (71610-822-26)
source: ndc

Packages (1)

Ingredients (1)

cilostazol (100 mg/1)

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "15ead24d-7d6b-b7ad-e063-6294a90ab1bb", "openfda": {"nui": ["N0000175598", "N0000175086"], "unii": ["N7Z035406B"], "rxcui": ["242461"], "spl_set_id": ["15ead884-bd4f-7f4b-e063-6394a90a8f81"], "pharm_class_epc": ["Phosphodiesterase 3 Inhibitor [EPC]"], "pharm_class_moa": ["Phosphodiesterase 3 Inhibitors [MoA]"], "manufacturer_name": ["Aphena Pharma Solutions - Tennessee, LLC"]}, "finished": true, "packaging": [{"sample": false, "description": "1200 TABLET in 1 BOTTLE (71610-822-26)", "package_ndc": "71610-822-26", "marketing_start_date": "20240412"}], "brand_name": "cilostazol", "product_id": "71610-822_15ead24d-7d6b-b7ad-e063-6294a90ab1bb", "dosage_form": "TABLET", "pharm_class": ["Phosphodiesterase 3 Inhibitor [EPC]", "Phosphodiesterase 3 Inhibitors [MoA]"], "product_ndc": "71610-822", "generic_name": "cilostazol", "labeler_name": "Aphena Pharma Solutions - Tennessee, LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "cilostazol", "active_ingredients": [{"name": "CILOSTAZOL", "strength": "100 mg/1"}], "application_number": "ANDA077030", "marketing_category": "ANDA", "marketing_start_date": "20111018", "listing_expiration_date": "20261231"}